Search Results

There are 12051 results for: content related to: Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree

  1. Gemcitabine-(5’-phosphoramidate)-[anti-IGF-1R]: Molecular Design, Synthetic Organic Chemistry Reactions, and Antineoplastic Cytotoxic Potency in Populations of Pulmonary Adenocarcinoma (A549)

    Chemical Biology & Drug Design

    Accepted manuscript online: 25 AUG 2016, C.P. Coyne and Lakshmi Narayanan

    DOI: 10.1111/cbdd.12845

  2. Intravesical gemcitabine for non-muscle invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Gabriel Jones, Anne Cleves, Timothy J Wilt, Malcolm Mason, Howard G Kynaston and Mike Shelley

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD009294.pub2

  3. You have free access to this content
    Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 496–505, Mike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason and Howard G. Kynaston

    Version of Record online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10880.x

  4. Synthesis and characterization of saccharide-functionalized polymer–gemcitabine conjugates based on chemoenzymatic selective strategy

    Journal of Applied Polymer Science

    Volume 124, Issue 3, 5 May 2012, Pages: 1840–1847, Guo-Jun Zhou, Xia Li, Ming-Xing Teng, Guo-Hai Chu and Xian-Fu Lin

    Version of Record online : 21 OCT 2011, DOI: 10.1002/app.35201

  5. Validation of a hydrophilic interaction ultra-performance liquid chromatography–tandem mass spectrometry method for the determination of gemcitabine in human plasma with tetrahydrouridine

    Biomedical Chromatography

    Volume 29, Issue 9, September 2015, Pages: 1343–1349, Yuji Mano, Kenji Sakamaki, Takuya Ueno, Kenji Kita, Takuho Ishii, Koichiro Hotta and Kazutomi Kusano

    Version of Record online : 2 FEB 2015, DOI: 10.1002/bmc.3429

  6. You have free access to this content
    Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

    The FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1261–1273, Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Minghua Zhu, Jiaxin Liang, Xiaoran Qin and Luyong Zhang

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1742-4658.2012.08521.x

  7. Labeling, biodistribution and evaluation of [125I] gemcitabine: a potential agent for tumor diagnosis and radiotherapy

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 52, Issue 3, March 2009, Pages: 91–97, O. A. El-Kawy, A. M. Hashem, M. A. Amin and A. S. El-Wetery

    Version of Record online : 16 JAN 2009, DOI: 10.1002/jlcr.1573

  8. You have free access to this content
    Synthesis and Biological Evaluation of Oral Prodrugs Based on the Structure of Gemcitabine

    Chemical Biology & Drug Design

    Volume 80, Issue 3, September 2012, Pages: 479–488, Cuirong Zhao, Xiaoxia Xue, Gang Li, Cuicui Sun, Changjun Sun, Xianjun Qu and Wenbao Li

    Version of Record online : 25 JUN 2012, DOI: 10.1111/j.1747-0285.2012.01422.x

  9. Interstitial lung disease associated with gemcitabine: A Japanese retrospective cohort study

    Respirology

    Volume 21, Issue 2, February 2016, Pages: 338–343, Tsuyoshi Hamada, Hideo Yasunaga, Yousuke Nakai, Hiroyuki Isayama, Hiroki Matsui, Kiyohide Fushimi and Kazuhiko Koike

    Version of Record online : 2 NOV 2015, DOI: 10.1111/resp.12665

  10. Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 2, March/April 2006, Pages: 507–514, C.J. POOLE, T. PERREN, S. GAWANDE, M. RIDDERHEIM, J. COOK, A. JENKINS and D. ROYCHOWDHURY

    Version of Record online : 25 APR 2006, DOI: 10.1111/j.1525-1438.2006.00466.x

  11. Ceramide metabolism determines glioma cell resistance to chemotherapy

    Journal of Cellular Physiology

    Volume 221, Issue 3, December 2009, Pages: 688–695, Claudia Alexandra Dumitru, Michael Weller and Erich Gulbins

    Version of Record online : 26 AUG 2009, DOI: 10.1002/jcp.21907

  12. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, Anne Cleves, Timothy J Wilt and Malcolm Mason

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD008976.pub2

  13. You have full text access to this OnlineOpen article
    Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 340–350, Yang Guo, Andreas Ziesch, Sandra Hocke, Eric Kampmann, Stephanie Ochs, Enrico N. De Toni, Burkhard Göke and Eike Gallmeier

    Version of Record online : 21 OCT 2014, DOI: 10.1111/jcmm.12444

  14. Advanced or Metastatic Pancreatic Cancer: Molecular Targeted Therapies

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 606–619, Soley Bayraktar and Caio M. Rocha-Lima

    Version of Record online : 23 NOV 2010, DOI: 10.1002/msj.20217

  15. Efficacy of a Poly-L-Glutamic Acid-Gemcitabine Conjugate in Tumor-Bearing Mice

    Drug Development Research

    Volume 73, Issue 3, May 2012, Pages: 120–129, Lik Voon Kiew, Soon Keng Cheong, Ernidila Ramli, Khalifah Sidik, Tuck Meng Lim and Lip Yong Chung

    Version of Record online : 7 MAY 2012, DOI: 10.1002/ddr.21012

  16. Development and validation of a stability indicating isocratic HPLC method for gemcitabine with application to drug release from poly lactic-co-glycolic acid nanoparticles and enzymatic degradation studies

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 11, November 2015, Pages: 1528–1536, Guanyu Chen, Darren Svirskis and Jingyuan Wen

    Version of Record online : 15 SEP 2015, DOI: 10.1111/jphp.12470

  17. You have full text access to this Open Access content
    RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells

    Journal of Cellular and Molecular Medicine

    Volume 12, Issue 6a, December 2008, Pages: 2334–2349, C. Yu, X. Zhang, G. Sun, X. Guo, H. Li, Y. You, J. L. Jacobs, K. Gardner, D. Yuan, Z. Xu, Q. Du, C. Dai, Z. Qian, K. Jiang, Y. Zhu, Q. Q. Li and Y. Miao

    Version of Record online : 6 FEB 2008, DOI: 10.1111/j.1582-4934.2008.00257.x

  18. You have free access to this content
    Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells

    FEBS Letters

    Volume 579, Issue 29, December 05, 2005, Pages: 6681–6687, Fuminori Teraishi, Lidong Zhang, Wei Guo, Fengqin Dong, John J. Davis, Anning Lin and Bingliang Fang

    Version of Record online : 14 NOV 2005, DOI: 10.1016/j.febslet.2005.10.064

  19. You have free access to this content
    Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma

    BJU International

    Volume 108, Issue 2, July 2011, Pages: 168–179, Michael D. Shelley, Anne Cleves, Timothy J. Wilt and Malcolm D. Mason

    Version of Record online : 1 JUL 2011, DOI: 10.1111/j.1464-410X.2011.10341.x

  20. Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma

    Journal of Surgical Oncology

    Volume 106, Issue 2, 1 August 2012, Pages: 174–180, Yoshiaki Murakami, Kenichiro Uemura, Takeshi Sudo, Yasushi Hashimoto, Akira Nakashima, Naru Kondo, Naoya Nakagawa and Taijiro Sueda

    Version of Record online : 13 FEB 2012, DOI: 10.1002/jso.23068